Both in Pharmaceuticals
Cadrenal Therapeutics vs Ernexa Therapeutics
Over the past year CVKD returned −91.9% and ERNA returned −89.2%; their daily moves had a correlation of -0.06.
CVKD −91.9% ERNA −89.2%Growth of $1, one year, split-adjusted
| Metric | CVKD | ERNA |
|---|---|---|
| Price | $1.09 | $3.16 |
| Market cap | $3.9M | $3.7M |
| Today | −2.68% | −8.93% |
| 1 month | −29.2% | −30.9% |
| 6 months | −74.4% | −33.1% |
| Year to date | −83.9% | −89.5% |
| 1 year | −92.2% | −88.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $2.4M | $5.0M |
| Dividend yield | — | — |
| Volatility (60d) | 83.0% | 104.2% |
| Short % of float | 4.0% | 1.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).